http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200948400-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
filingDate | 2009-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82ea4aed4f008da4aa79f680c5179eef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4420271dedf6eeefa2fd7b6ad43b55f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1869ba8151616063e2baf9d673843d07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba966960363caad8f9cf8477a138013a |
publicationDate | 2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-200948400-A |
titleOfInvention | Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet |
abstract | The present invention refers to a process for preparing a powder comprising the steps of providing at least one first component being in liquid form at ambient temperature, in particular having a viscous liquid consistency, such as for example an oil; or having a waxy consistency, in particular being a solid or semi-solid at ambient temperature with an onset of melting in the temperature range of 15 DEG C to 40 DEG C providing at least one second component having a melting point or melting range above ambient temperature and below the degradation temperature of said first component, in particular above ambient temperature and below 120 DEG C, in particular between > 40 DEG C and below 120 DEG C, more in particular between 50 DEG C and below 120 DEG C, even more in particular between 55 DEG C and below 120 DEG C, forming a homogenous liquid mixture comprising said at least one first component and said at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature above the meting point or melting range of said second component and below the degradation temperature of said first component, in particular above the melting point or melting range of said second component and below 120 DEG C, transferring the liquid mixture to at least one spray congealing unit by at least one transfer unit, which is adapted to keep the mixture in its liquid form during its transfer, spray congealing said mixture, and isolating the powder obtained upon spray congealing. Further, the present invention refers to a process for the preparation of a solid dosage form comprising the powder resulting from the above process. |
priorityDate | 2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 826.